To have full access to all the product information on this site, registration is required.
The first intradermal PCV vaccine
- Advancing how the swine industry vaccinates by providing an alternative to intramuscular (IM) vaccines
- Low-volume 0.2-mL dose administered into the dermis with the needle-free IDAL System
- Approved for concurrent use with Porcilis M Hyo ID ONCE
- PCV2 DOI is 23 weeks after vaccination
- Complements our line of ID vaccines to protect against the top three swine pathogens: PCV2, M. hyo and PRRSv